Steroid use reduces infusion reactions to infliximab in patients with Crohn's disease

被引：0
|
作者：
Brzezinski, A
Kumar, J
Lashner, BA
Shen, B
Achkar, JP
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)80972-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A194 / A194
页数：1
相关论文
共 50 条
  • [1] Risk factors for infusion reactions of infliximab in patients with Crohn's disease
    Inaba, Y.
    Taruishi, M.
    Fujiya, M.
    Saitoh, Y.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S371 - S372
  • [2] The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn's disease
    Moss, A. C.
    Fernandez-Becker, N.
    Kim, K. Jo
    Cury, D.
    Cheifetz, A. S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (02) : 221 - 227
  • [3] Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions
    Duburque, C.
    Lelong, J.
    Iacob, R.
    Seddik, M.
    Desreumaux, P.
    Fournier, C.
    Wallaert, B.
    Cortot, A.
    Colombel, J. -F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (05) : 851 - 858
  • [4] Successful desensitization to infliximab in patients with Crohn's disease with prior severe infusion reactions.
    Duburque, C
    Lelong, J
    Desreumaux, P
    Fournier, C
    Wallaert, B
    Colombel, JF
    GASTROENTEROLOGY, 2005, 128 (04) : A577 - A577
  • [5] Infliximab treatment reduces pain in patients with Crohn's disease
    Lichtenstein, GR
    Colombel, JF
    Yan, SK
    Bala, M
    Olson, A
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S250 - S250
  • [6] Desensitization protocol for infliximab use in Crohn's disease patients with prior reactions.
    Smedley, MV
    Plevy, S
    Mayer, L
    GASTROENTEROLOGY, 2002, 122 (04) : A615 - A615
  • [7] Infliximab reduces Hypercoagulability in Patients with Crohn's Disease and Ulcerative Colitis
    Franke, Katharina
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (11): : 1046 - 1046
  • [8] Infliximab use in Crohn's disease
    Bewtra, M
    Lichtenstein, GR
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (04) : 589 - 599
  • [9] Resource use in patients with Crohn's disease treated with infliximab
    Saro, C.
    de la Coba, C.
    Casado, M. A.
    Morales, J. M.
    Otero, B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (10) : 1313 - 1323
  • [10] Post infusion infliximab levels determine duration of response in Crohn's disease and are directly related to infusion reactions
    Noman, M
    Baert, F
    Vermeire, S
    Van Assche, G
    D'Haens, G
    Carbonez, A
    Rutgeerts, P
    GASTROENTEROLOGY, 2002, 122 (04) : A100 - A100
12345